Here are 14 recent news updates on key gastroenterology and endoscopy companies.
GI & Endoscopy
A poster presented at Digestive Disease Week 2016, May 21 to May 24 in San Diego, showed that primary care physicians and gastroenterologists differ on reasons for recommending surveillance colonoscopy to patients 75 years and older, according to a MedPage…
Janssen Research & Development presented Phase 3 data showing the efficacy of STELARA subcutaneous maintenance therapy in treating patients with moderate-to-severe Crohn's disease.
A study presented at Digestive Disease Week 2016 found Medigus' MUSE system is a safe minimally-invasive alternative for the long-term treatment of gastroesophageal reflux disease.
Redwood City, Calif.-based C2 Therapeutics presented data from four separate clinical studies at Digestive Disease Week 2016 that found the company's CryoBalloon Focal Ablation System to be safe and effective.
Advertisement
A study published in Gastroenterology found the Low Fermentable Oligo-Di-Monosaccharides and Polyols diet was effective in treating patients with irritable bowel syndrome, Science Daily reports.
Frank G. Gress, MD, is chief of the digestive disease division at Columbia University Medical Center in New York City. He is also chief of the therapeutic endoscopy program at Columbia University Medical Center.
EndoChoice released its RescueNet retrieval device.
Here are 33 AGA Research Foundation award recipients for 2016.
The Northwestern Medicine Digestive Health Foundation raised $1.2 million at its inaugural benefit in Chicago, according to the Chicago Tribune.